Media coverage about BioLife Solutions (NASDAQ:BLFS) has been trending positive this week, according to Accern Sentiment. The research group ranks the sentiment of news coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. BioLife Solutions earned a media sentiment score of 0.27 on Accern’s scale. Accern also assigned news coverage about the medical equipment provider an impact score of 46.0036431185709 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:

Separately, Maxim Group set a $7.00 target price on BioLife Solutions and gave the stock a “buy” rating in a report on Thursday, October 19th.

BioLife Solutions (NASDAQ BLFS) opened at $5.18 on Tuesday. BioLife Solutions has a 1 year low of $1.43 and a 1 year high of $7.53.

BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings data on Thursday, August 10th. The medical equipment provider reported ($0.06) earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.06). BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%. The business had revenue of $2.56 million for the quarter, compared to analysts’ expectations of $2.40 million. equities analysts forecast that BioLife Solutions will post -0.24 EPS for the current year.

ILLEGAL ACTIVITY WARNING: “Positive Media Coverage Somewhat Unlikely to Impact BioLife Solutions (BLFS) Share Price” was first published by Watch List News and is the sole property of of Watch List News. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Insider Buying and Selling by Quarter for BioLife Solutions (NASDAQ:BLFS)

Receive News & Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.